ACSL4 and metastatic melanoma: Therefore, although further studies are required, and an extended panel of metastatic melanoma cell lines should be screened to verify this relation, it is possible to speculate that this factor might represent a new potential marker to predict metastatic melanoma sensitivity to ferroptotic cell death, possibly coupled to other potential markers such as ACSL4.